QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results
January 26 2021 - 7:10AM
Business Wire
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA)
announced today that it plans to release its report on results for
the fourth quarter and full-year 2020 on Tuesday, February 9,at
approximately 22:05 Central European Time (CET) /
16:05 Eastern Standard Time (EST).
A conference call is planned for Wednesday, February 10, at
15:00 CET / 9:00 EST, hosted by Thierry Bernard,
Chief Executive Officer, and Roland Sackers, Chief Financial
Officer.
Conference call and webcast details
Interested parties may listen to the call
by dialing:
+1 646 828 8193 (U.S.), +44 (0)330 336 9411 (UK), +49 (0)69 2222
2018 (Germany).
To avoid waiting time, please join the event conference 5-10
minutes prior to the start time.
Conference ID: 2900586
The webcast will be accessible at: https://globalmeet.webcasts.com/viewer/event.jsp?ei=1422345&tp_key=e2c7f9a1ee
A conference call replay will be available by using the
following link: https://globalmeet.webcasts.com/viewer/event.jsp?ei=1422345&tp_key=e2c7f9a1ee
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample to Insight solutions that enable
customers to gain valuable molecular insights from samples
containing the building blocks of life. Our sample technologies
isolate and process DNA, RNA, and proteins from blood, tissue, and
other materials. Assay technologies make these biomolecules visible
and ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights. Automation
solutions tie these together in seamless and cost-effective
workflows. QIAGEN provides solutions to more than 500,000 customers
around the world in Molecular Diagnostics (human healthcare) and
Life Sciences (academia, pharma R&D, and industrial
applications, primarily forensics). As of September 30, 2020,
QIAGEN employed more than 5,300 people in over 35 locations
worldwide. Further information can be found at
http://www.qiagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210126005602/en/
John Gilardi Vice President Head of Corporate Communications and
Investor Relations +49 2103 29 11711 +1 240 686 2222 Email:
ir@qiagen.com
Phoebe Loh Associate Director Investor Relations +49 2103 29
11457 Email: ir@qiagen.com
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024